Evidence map›Paper›PMID 36793243›Full record

Observational studyEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2023

Ambulatory pulmonary vein isolation workflow using the Perclose ProglideTM suture-mediated vascular closure device: the PRO-PVI study.

Davide Fabbricatore, Dimitri Buytaert, Chiara Valeriano, Niya Mileva, Pasquale Paolisso, Sakura Nagumo, Daniel Munhoz, Carlos Collet, Tom De Potter

Erratum issuedOpen access · hybridAbstract readObservational Study
In one paragraph

Observational study in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Venous vascular closure system vs. figure-of-eight suture following atrial fibrillation ablation: the STYLE-AF Study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Trial
  3. Article
  4. Optimising the atrial fibrillation ablation pathway using vascular closure devices: effects on length of stay, procedure time and outcomes.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2026
    Article
  5. Same-day discharge after electrophysiological and cardiac implantable electronic device procedures: a clinical consensus statement of the European Heart Rhythm Association (EHRA) and the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Review
  6. [Vascular closure following electrophysiological procedures-a practical guide].Herzschrittmachertherapie & Elektrophysiologie · 2026
    Review
  7. Review
  8. Pulsed field ablation-based pulmonary vein isolation utilizing a simplified approach or a standard approach-insights from the fast and furious PFA study.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  9. Vascular access and closure management for electrophysiological interventions in 2025: a Clinical Consensus Statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Surgery.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  10. Article
  11. Impact of venous closure systems on time to ambulation and discharge following AF ablation: a systematic review and meta-analytic review.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2025
    Review
  12. Article
  13. Vascular access site management during electrophysiology procedures: a European Heart Rhythm Association survey.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 3 countries.

Davide FabbricatoreCardiovascular Center Aalst, OLV Hospital, Moorselbaan 164, 9300 Aalst, Belgium.ORCID 0000-0002-5622-3233
Dimitri BuytaertCardiovascular Center Aalst, OLV Hospital, Moorselbaan 164, 9300 Aalst, Belgium.ORCID 0000-0003-0592-5873
Chiara ValerianoCardiovascular Center Aalst, OLV Hospital, Moorselbaan 164, 9300 Aalst, Belgium.ORCID 0000-0002-0130-6218
Niya MilevaCardiovascular Center Aalst, OLV Hospital, Moorselbaan 164, 9300 Aalst, Belgium.ORCID 0000-0002-4666-0181
Pasquale PaolissoCardiovascular Center Aalst, OLV Hospital, Moorselbaan 164, 9300 Aalst, Belgium.ORCID 0000-0002-7017-778X
Sakura NagumoCardiovascular Center Aalst, OLV Hospital, Moorselbaan 164, 9300 Aalst, Belgium.
Daniel MunhozCardiovascular Center Aalst, OLV Hospital, Moorselbaan 164, 9300 Aalst, Belgium.ORCID 0000-0002-8951-4504
Carlos ColletCardiovascular Center Aalst, OLV Hospital, Moorselbaan 164, 9300 Aalst, Belgium.ORCID 0000-0001-5792-2549
Tom De PotterCardiovascular Center Aalst, OLV Hospital, Moorselbaan 164, 9300 Aalst, Belgium.ORCID 0000-0003-1424-114X
Onze Lieve Vrouwziekenhuis Hospital · BE

Funding

Abbott VascularUniversity of Naples Federico II
6 · The paper itself

Abstract

aimsThe leading reason for delayed discharge after pulmonary vein isolation (PVI) is vascular complications. This study aimed to evaluate feasibility, safety, and efficacy of the Perclose Proglide™ suture-mediated vascular closure in ambulatory PVI, report complications, patient satisfaction, and cost of this approach. METHODS AND

resultsPatients scheduled for PVI were enrolled prospectively in an observational design. Feasibility was assessed as % discharged the day of procedure. Efficacy was analysed as acute access site closure rate, time to reach haemostasis, time to ambulate, and time to discharge. Safety analysis consisted of vascular complications at 30 days. Cost analysis was reported using direct and indirect cost analysis. A 1:1 propensity matched control cohort was used for comparing time to discharge to usual workflow. Of 50 enrolled patients, 96% were discharged on the same day. 100% of devices were successfully deployed. Immediate (<1 min) haemostasis was reached in 30 patients (62.5%). Mean time to discharge was 5:48 ± 1:03 h (vs. 10:16 ± 1:21 h in the matched cohort, P < 0.0001). Patients reported high level of satisfaction with the post-operative time. No major vascular complication occurred. Cost analysis showed a neutral impact compared to the standard of care.

conclusionThe use of the closure device for femoral venous access after PVI led to safe discharge of patients within 6 h from the intervention in 96% of the population. This approach could minimize the overcrowding of healthcare facilities. The gain in post-operative recovery time improved patients' satisfaction and balanced the economic cost of the device.

Indexed as

Pulmonary VeinsVascular Closure DevicesHumansSuturesTreatment OutcomeWorkflowAmbulatory managementAtrial fibrillationFemoral accessPerclose ProGlide™Pulmonary vein isolationRapid discharge

Identifiers

PMID36793243
PMCPMC10105833
OpenAlexW4321002299

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.